JP2551318B2 - Infusion container - Google Patents
Infusion containerInfo
- Publication number
- JP2551318B2 JP2551318B2 JP5100205A JP10020593A JP2551318B2 JP 2551318 B2 JP2551318 B2 JP 2551318B2 JP 5100205 A JP5100205 A JP 5100205A JP 10020593 A JP10020593 A JP 10020593A JP 2551318 B2 JP2551318 B2 JP 2551318B2
- Authority
- JP
- Japan
- Prior art keywords
- container
- drug
- cap
- guide
- wall
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001802 infusion Methods 0.000 title claims description 33
- 239000003814 drug Substances 0.000 claims description 101
- 229940079593 drug Drugs 0.000 claims description 88
- 239000002775 capsule Substances 0.000 claims description 51
- 238000004891 communication Methods 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 29
- 238000004090 dissolution Methods 0.000 claims description 21
- 238000007789 sealing Methods 0.000 claims description 13
- 229920003002 synthetic resin Polymers 0.000 claims description 11
- 239000000057 synthetic resin Substances 0.000 claims description 11
- 238000003825 pressing Methods 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 50
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 8
- 239000012528 membrane Substances 0.000 description 6
- 238000005192 partition Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
- B65D81/3205—Separate rigid or semi-rigid containers joined to each other at their external surfaces
- B65D81/3211—Separate rigid or semi-rigid containers joined to each other at their external surfaces coaxially and provided with means facilitating admixture
Description
【０００１】[0001]
【産業上の利用分野】本発明は輸液用容器に関する。さ
らに詳しくは、粉末製剤や凍結乾燥製剤、固形製剤など
の乾燥薬剤と、その溶解液を分離した状態で保存してお
き、使用直前に容器内で乾燥薬剤と溶解液とを無菌的に
混合し、液状の薬品として供給するための輸液用容器に
関する。FIELD OF THE INVENTION The present invention relates to a container for infusion. More specifically, dry drugs such as powdered preparations, freeze-dried preparations, and solid preparations and their dissolved solutions are stored in a separated state, and the dried drug and the dissolved solutions are aseptically mixed in a container immediately before use. , A container for infusion for supplying as a liquid medicine.
【０００２】[0002]
【従来の技術】従来より病院などの医療機関において
は、バイアル等の薬剤容器に入った乾燥薬剤を蒸留水や
生食、ブドウ糖液などの溶解液（他の薬液を含む）に溶
解して点滴注射などに用いている。このような場合に簡
便に使用できるように、乾燥薬剤を収容したバイアルを
溶解液を収納した可撓性容器に直列状に連結しておき、
使用時にこれら二つの容器を無菌的に連通するようにし
た輸液用容器が提案されている（特表昭６１−５０１１
２９号公報、特開平２−１２７７号公報、実開昭６３−
１３５６４２号公報など）。2. Description of the Related Art Conventionally, in medical institutions such as hospitals, a dried drug contained in a drug container such as a vial is dissolved in distilled water, a saline solution, a solution such as glucose solution (including other drug solutions), and then an intravenous injection is made. It is used for In order to easily use in such a case, the vial containing the dry drug is connected in series to the flexible container containing the solution,
An infusion container has been proposed in which these two containers are aseptically communicated at the time of use (Japanese Patent Publication No. 61-5011).
No. 29, JP-A No. 2-1277, and Japanese Utility Model Laid-Open No. 63-
135642, etc.).
【０００３】特表昭６１−５０１１２９号公報に示され
るものは、薬剤容器の収容されたカプセルと溶解液の収
容された可撓性容器とがチューブで接続されたものであ
り、チューブ内に設けられた連通手段によって薬剤容器
と可撓性容器が連通され、薬剤と溶解液とが無菌的に混
合されるようになっている。また、特開平２−１２７７
号公報に示されるものは、薬剤容器の収容されたカプセ
ルをその結合部で溶解液容器の口部と接続し、カプセル
の結合部側に連通順序規制手段をそなえた連通手段を介
在させたもので、連通手段により薬剤容器が刺通された
のちに溶解液容器が刺通されて二つの容器が連通され、
薬剤と溶解液とが無菌的に混合されるようになってお
り、実開昭６３−１３５６４２号公報に示すものは、溶
解液容器の口部のシール部に筒状の適宜取外し可能なサ
ポートリングを設け、このサポートリングに上下スライ
ド自在に両頭針を取り付けたものであり、両頭針を下方
にスライドさせたときに、下部針体が溶解液容器の口部
のシール部に穿刺するようにしたものである。The one disclosed in Japanese Patent Publication No. 61-501129 is that in which a capsule containing a drug container and a flexible container containing a solution are connected by a tube, which is provided in the tube. The medicine container and the flexible container are communicated with each other by the communication means so that the medicine and the solution are aseptically mixed. In addition, JP-A-2-1277
What is disclosed in the publication is that the capsule containing the drug container is connected to the mouth of the dissolution liquid container at its joint, and the communication means having the communication sequence regulating means is interposed on the joint side of the capsule. Then, after the drug container is pierced by the communication means, the dissolution liquid container is pierced and the two containers are communicated,
The drug and the dissolution liquid are mixed aseptically, and the one disclosed in Japanese Utility Model Laid-Open No. 63-135642 discloses a tubular support ring which is appropriately removable in the seal portion at the mouth of the dissolution liquid container. A double-ended needle is attached to this support ring so that it can slide up and down, and when the double-ended needle is slid downward, the lower needle body punctures the seal part at the mouth of the solution container. It is a thing.
【０００４】[0004]
【発明の解決しようとする課題】前記従来の輸液用容器
はいずれも乾燥薬剤の一般的な流通形態であるバイアル
をそのまま取り込み一体化したものであり、その意味で
汎用性が高い。しかしながら、これら従来の輸液用容器
は、例えば、特表昭６１−５０１１２９号公報の輸液用
容器は、部品点数が多い上、破断部材を手で折って通路
を開通するのに手間を要する、破断部材の折れ方が不完
全な場合には、液が通りにくく、溶解に時間がかかる、
という欠点を有しており、また、特開平２−１２７７号
公報の輸液用容器は、内部薬剤の汚染の防止および薬剤
容器と溶解液容器との連通の簡素化という点に関して
は、前記特表昭６１−５０１１２９号公報の輸液用容器
と比べてかなり改良されたとはいうものの、連通順序規
制手段等の部品が複雑であるとともに全体に部品点数が
多いという欠点を有しており、さらにまた実開昭６３−
１３５６４２号公報の輸液用容器は、部品点数が少な
く、操作は比較的容易ではあるが、連通に比較的大きな
力を要する、薬剤と溶解液を混合後サポートリングおよ
び両頭針を取り外して溶解液容器を反転させ、両頭針を
抜き取った後の溶解液容器の口部のシール部に輸液セッ
トなどを接続する必要があるため、操作に手間がかか
る、両頭針抜取時に混合された薬液が漏れる虞がある、
などの欠点を有している。Each of the conventional infusion containers described above is a container in which a vial, which is a general distribution form of a dry drug, is directly incorporated and integrated, and in that sense, it is highly versatile. However, these conventional infusion containers, for example, the infusion container disclosed in Japanese Patent Publication No. 61-501129 has a large number of parts, and it takes time to break the breaking member by hand to open the passage. If the member is not completely broken, it will be difficult for the liquid to pass through and it will take time to dissolve.
In addition, the infusion container disclosed in Japanese Patent Application Laid-Open No. 2-1277 discloses, in terms of prevention of contamination of the internal medicine and simplification of communication between the medicine container and the dissolution liquid container, the above-mentioned special table. Although it is considerably improved as compared with the infusion container disclosed in Japanese Patent Laid-Open No. 61-501129, it has drawbacks in that the parts such as the communication sequence regulating means are complicated and the total number of parts is large. Kaisho 63-
The solution container of 135642 has a small number of parts and is relatively easy to operate, but requires a relatively large force for communication. After mixing the drug and the solution, the support ring and the double-ended needle are removed to dissolve the solution container. Since it is necessary to invert and connect an infusion set etc. to the seal part at the mouth of the dissolution liquid container after the double-ended needle is withdrawn, it takes time to operate, and there is a risk that the mixed drug solution will leak when the double-ended needle is withdrawn. is there,
It has drawbacks such as
【０００５】本発明は上記のような事情に鑑みてなされ
たもので、操作が容易で手間がかからず、混合された薬
液が漏れる虞がなく、部品点数の少ない、無菌的に薬剤
と溶解液を混合することのできる輸液用容器を提供する
ことを目的とする。The present invention has been made in view of the above circumstances, and it is easy to operate, hassle-free, there is no risk of leaking a mixed drug solution, the number of parts is small, and the drug is aseptically dissolved. It is an object of the present invention to provide an infusion container capable of mixing liquids.
【０００６】[0006]
【課題を解決するための手段】本発明は上記の課題を解
決するために、口部がゴム栓で密封された薬剤容器と、
該薬剤容器との連通口と薬液取出口とをその両端に有す
る押圧変形自在な合成樹脂製の溶解液容器と、該薬剤容
器の口部と溶解液容器の連通口の間に介在された上下両
端に穿刺針を有する両頭針と、開放端と前記溶解液容器
の連通口外壁との結合端を有し、前記薬剤容器の一部お
よび両頭針を下方向スライド可能に収容するガイドカプ
セル、および該ガイドカプセルの開放端を密封するキャ
ップから構成されてなり、キャップの内壁とガイドカプ
セルの内壁および薬剤容器の外壁に、協働して薬剤容器
を下方移動させる薬剤容器押下手段を設け、キャップを
回転させた時に薬剤容器が回転することなく下方移動し
て両頭針に達し、さらに該両頭針とともに下方移動する
ことにより、薬剤容器の口部のゴム栓と溶解液容器の連
通口の密閉部材が両頭針によって刺通され、薬剤容器と
溶解液容器が連通されるようにしてなる輸液用容器を採
用している。In order to solve the above problems, the present invention provides a drug container having a mouth portion sealed with a rubber stopper,
A solution container made of a synthetic resin that is press-deformable and has a communication port with the drug container and a drug solution outlet at its both ends, and an upper and lower part interposed between the mouth part of the drug container and the communication port of the solution container. A double-ended needle having puncture needles at both ends, a guide capsule having a connecting end of the open end and the outer wall of the communication port of the dissolution liquid container, and a part of the drug container and the double-ended needle to be slidable downward, and The cap comprises a cap that seals the open end of the guide capsule, and the inner wall of the cap, the inner wall of the guide capsule and the outer wall of the drug container are provided with drug container pressing means for moving the drug container downward, and the cap is attached. When rotated, the drug container moves downward without rotating to reach the double-ended needle, and further moves downward together with the double-ended needle, whereby the rubber stopper at the mouth of the drug container and the sealing member at the communication port of the solution container are closed. Pierced by-ended needle, the drug container and solvent container adopts a fluid vessel comprising so as to be communicated.
【０００７】[0007]
【作用】図１において、薬剤容器１に外嵌されたバイア
ルガイド６の第２の係合突起６２がガイドカプセル４の
縦走溝４１に嵌められ、第１の係合突起６１がキャップ
５の螺旋溝５１に嵌められている。この構成では、キャ
ップ５を時計回り方向に回転した時に、バイアルガイド
６が第２の係合突起６１と縦走溝４１の係合によりキャ
ップ５とともに回転することがないので、第１の係合突
起６１はキャップ５の螺旋溝５１に沿って下方に移動す
る。従って、キャップ５を時計回り方向に回転させる
と、薬剤容器１はバイアルガイド６とともに下方移動
し、先ず薬剤容器１の口部１１のゴム栓１２が両頭針３
の上部穿刺針３２によって戦死され、バイアルガイド６
は薬剤容器１と両頭針３とともに更に下方移動し、薬液
容器１のゴム栓１２および溶解液容器２の閉鎖膜２２が
それぞれ両頭針３の上部穿刺針３２および下部穿刺針３
３によって刺通される。このようにして、薬剤容器１と
溶解液容器２の連通操作はキャップ５の回転によって極
めて容易に達成される。In FIG. 1, the second engaging projection 62 of the vial guide 6 externally fitted to the medicine container 1 is fitted in the longitudinal groove 41 of the guide capsule 4, and the first engaging projection 61 is the spiral of the cap 5. It is fitted in the groove 51. In this configuration, when the cap 5 is rotated in the clockwise direction, the vial guide 6 does not rotate together with the cap 5 due to the engagement of the second engaging protrusion 61 and the longitudinal groove 41, and thus the first engaging protrusion. Reference numeral 61 moves downward along the spiral groove 51 of the cap 5. Therefore, when the cap 5 is rotated in the clockwise direction, the drug container 1 moves downward together with the vial guide 6, and first, the rubber stopper 12 of the mouth portion 11 of the drug container 1 is moved to the double-ended needle 3.
Was killed by the upper puncture needle 32 and the vial guide 6
Moves further downward together with the drug container 1 and the double-ended needle 3, and the rubber stopper 12 of the drug solution container 1 and the closing film 22 of the solution container 2 are respectively the upper puncture needle 32 and the lower puncture needle 3 of the double-ended needle 3.
Pierced by 3. In this way, the communication operation between the drug container 1 and the solution container 2 is extremely easily achieved by rotating the cap 5.
【０００８】[0008]
【実施例】次に本発明の実施例について図面に基づいて
説明する。図１は本発明の輸液用容器の一実施例の断面
図、図２〜図１４は図１の輸液用容器の主な構成要素を
説明するための図であり、図２は薬剤容器の断面図、図
３は溶解液容器の断面図、図４は図３の平面図、図５は
両頭針の断面図、図６は図５の底面図、図７は図５の平
面図、図８はバイアルガイドの断面図、図９は図８の底
面図、図１０はガイドカプセルの断面図、図１１は図１
０の平面図、図１２はキャップの側面図、図１３は図１
２のＸ−Ｘ線断面図、図１４は図１２の平面図である。
また、図１５は他の実施例の要部断面図であり、図１６
は図１５のスタンドの断面図、図１７は図１６の底面図
である。Embodiments of the present invention will now be described with reference to the drawings. 1 is a cross-sectional view of an embodiment of the infusion container of the present invention, FIGS. 2 to 14 are views for explaining main components of the infusion container of FIG. 1, and FIG. 2 is a cross-section of a drug container. FIG. 3, FIG. 3 is a cross-sectional view of the solution container, FIG. 4 is a plan view of FIG. 3, FIG. 5 is a cross-sectional view of a double-ended needle, FIG. 6 is a bottom view of FIG. 5, FIG. 7 is a plan view of FIG. Is a sectional view of a vial guide, FIG. 9 is a bottom view of FIG. 8, FIG. 10 is a sectional view of a guide capsule, and FIG. 11 is FIG.
0 is a plan view, FIG. 12 is a side view of the cap, and FIG. 13 is FIG.
2 is a sectional view taken along line XX of FIG. 2, and FIG. 14 is a plan view of FIG.
Further, FIG. 15 is a sectional view of an essential part of another embodiment.
15 is a sectional view of the stand of FIG. 15, and FIG. 17 is a bottom view of FIG.
【０００９】図１に示すように、本発明の輸液用容器
は、薬剤容器１と溶解液容器２、両頭針３、ガイドカプ
セル４、キャップ５、バイアルガイド６から構成されて
おり、ガイドカプセル４はその結合部４３で連通口２１
に結合されるとともに、その開放端がキャップ５で密閉
され、ガイドカプセル４の中には両頭針３とその口部１
１を下向きにした薬剤容器１の口部１１側がこの順序で
下方向スライド可能に収容されている。また、薬剤容器
１はバイアルガイド６にその口部１１を外に出して挿着
されている。そして、キャップ５を時計回りに回転させ
ると、薬剤容器１がバイアルガイド６とともに下降し
て、両頭針３によって薬剤容器１のゴム栓１２および溶
解液容器２の閉鎖膜２２が刺通され、両容器１、２が連
通されるようになっている。As shown in FIG. 1, the infusion container of the present invention comprises a drug container 1, a solution container 2, a double-ended needle 3, a guide capsule 4, a cap 5 and a vial guide 6, and the guide capsule 4 Is the connecting portion 43 of the communication port 21
And the open end of the guide capsule 4 is sealed with a double-ended needle 3 and its mouth 1.
The mouth portion 11 side of the drug container 1 with 1 facing downward is housed so as to be slidable downward in this order. Further, the drug container 1 is attached to the vial guide 6 with its mouth portion 11 exposed. Then, when the cap 5 is rotated clockwise, the drug container 1 is lowered together with the vial guide 6, and the double-ended needle 3 pierces the rubber stopper 12 of the drug container 1 and the closing film 22 of the solution container 2, The containers 1 and 2 are communicated with each other.
【００１０】薬剤容器１は一般にガラス製であり、図２
に示すように、その口部１１はゴム栓１２などの密封部
材で密封されており、ゴム栓１２はさらにアルミなどで
作られたカバー部材１３で巻締めされ、口部１１に固定
されている。薬剤容器１としては市販の薬剤容器が使用
可能であり、輸液用容器の組立に際しては、カバー部材
１３はその天面が取り外され、両頭針３の穿刺針を穿刺
する位置に透孔１４が形成される。薬剤容器１の胴部１
５の外壁に、図１に示すようなバイアルガイド６の第１
の係合突起６１や第２の係合突起６２に相当する係合突
起を設け、バイアルガイド６を省略してもよいが、ガラ
ス製の薬剤容器に係合突起を形成することは難しいの
で、合成樹脂でバイアルガイド６を形成し、この中に薬
剤容器１を挿着するのが好ましい。尚、薬剤容器１内に
は粉末製剤や固形製剤、凍結乾燥製剤などの乾燥製剤が
収容されているが、図面では省略している。The drug container 1 is generally made of glass, as shown in FIG.
As shown in FIG. 4, the mouth 11 is sealed with a sealing member such as a rubber stopper 12, and the rubber stopper 12 is further wound by a cover member 13 made of aluminum or the like and fixed to the mouth 11. . A commercially available drug container can be used as the drug container 1. When assembling the infusion container, the top surface of the cover member 13 is removed and a through hole 14 is formed at a position where the double-ended needle 3 is punctured by the puncture needle. To be done. Body part 1 of drug container 1
On the outer wall of 5, the first of the vial guide 6 as shown in FIG.
The engagement protrusions 61 and the second engagement protrusions 62 may be provided and the vial guide 6 may be omitted, but it is difficult to form the engagement protrusions on the glass drug container. It is preferable to form the vial guide 6 from a synthetic resin and insert the drug container 1 therein. The drug container 1 contains a dry preparation such as a powder preparation, a solid preparation, and a freeze-dried preparation, but they are omitted in the drawing.
【００１１】薬剤容器１を図１に示すように収容してこ
れを保持するとともに、薬剤容器１をこれが回転しない
ように下方に移動させるための補助具として機能するバ
イアルガイド６は、通常ポリエチレンやポリプロピレ
ン、ポリエステル、ポリ塩化ビニル、ポリカーボネー
ト、ＡＢＳ樹脂などの合成樹脂で形成されており、図８
および図９に示すように、底部６３と口部６４および胴
部６５からなる筒状の部材である。底部６３には、後述
のキャップ５の螺旋溝５１に嵌め込まれ、この螺旋溝５
１に沿って下方に移動する複数の第１の係合突起６１
（図では軸対称に２個形成されている）と、薬剤容器１
を挿着した時に空気を抜くための透孔６６が形成されて
おり、口部６４には、後述のガイドカプセル４の縦走溝
４１に嵌め込まれ、この縦走溝４１に沿って下方に移動
する複数の第２の係合突起６２（図では底面図上第１の
係合突起６１と同じ位置に２個形成されている）と、薬
剤容器１をこれが脱落しないように押さえる環状突起６
８が形成されている。口部６４には、好ましくは、薬剤
容器１を挿着し易くするために複数のスリット６７を設
けてもよい。尚、キャップ５を取り外せるようにした場
合には、バイアルガイド６の天面に把手６９を設けても
よく、これにより、把手６９を手でつかんで薬剤容器１
を容易にガイドカプセル３から取り出せるようにするこ
とができる。The vial guide 6, which functions as an auxiliary tool for accommodating and holding the drug container 1 as shown in FIG. 1 and for moving the drug container 1 downward so as not to rotate, is usually polyethylene or the like. It is made of synthetic resin such as polypropylene, polyester, polyvinyl chloride, polycarbonate, and ABS resin.
And as shown in FIG. 9, it is a tubular member composed of a bottom portion 63, a mouth portion 64, and a body portion 65. The bottom portion 63 is fitted into a spiral groove 51 of the cap 5, which will be described later, and the spiral groove 5
A plurality of first engaging protrusions 61 that move downward along
(In the figure, two are formed in axial symmetry) and the drug container 1
Has a through hole 66 for removing air when it is attached, and the mouth portion 64 is fitted into a longitudinal groove 41 of a guide capsule 4 described later, and a plurality of holes are moved downward along the longitudinal groove 41. Second engaging projections 62 (two are formed at the same position as the first engaging projections 61 in the bottom view in the figure), and the annular projection 6 that holds the drug container 1 so as not to fall off.
8 are formed. The mouth portion 64 may preferably be provided with a plurality of slits 67 to facilitate insertion of the drug container 1. When the cap 5 can be removed, a handle 69 may be provided on the top surface of the vial guide 6, whereby the drug container 1 can be grasped by hand.
Can be easily removed from the guide capsule 3.
【００１２】この薬剤容器１を挿着したバイアルガイド
６はその一部が両頭針３とともにガイドカプセル４に収
容される。ガイドカプセル４は通常バイアルガイド６と
同様の合成樹脂で製せられた筒状の容器で、図１０およ
び図１１に示すように両端に開放端と結合端を有してい
る。開放端側に近接して、図１に示すキャップ取外し手
段８を介してキャップ５と結合するための環状突起４９
が形成されており、ガイドカプセル４の内壁には結合端
側の隔壁４８から開放端に向かって縦走する複数の溝が
形成されている。溝は開放端近傍まで縦走する複数の縦
走溝４１（図では軸対称に２個形成されている）と、そ
れより短い複数の両頭針係合溝４４（図では縦走溝４１
を含み軸対称に４個形成されている）からなる。縦走溝
４１はバイアルガイド６の第２の係合突起６２と係合し
てバイアルガイド６を回転させずに下降させるためのも
のであり、本実施例では両頭針３が４本の係合腕３４を
有している関係で両頭針係合溝４４を兼ねさせている。
尚、両頭針係合溝４４には両頭針３の位置決めのための
段部（図示していない）を設けてもよい。A part of the vial guide 6 having the drug container 1 inserted therein is accommodated in the guide capsule 4 together with the double-ended needle 3. The guide capsule 4 is usually a cylindrical container made of the same synthetic resin as that of the vial guide 6, and has open ends and connecting ends at both ends as shown in FIGS. 10 and 11. An annular protrusion 49 for coupling with the cap 5 via the cap removing means 8 shown in FIG. 1 close to the open end side.
Is formed, and a plurality of grooves are formed on the inner wall of the guide capsule 4 so as to extend vertically from the partition wall 48 on the coupling end side toward the open end. The grooves are a plurality of longitudinal grooves 41 that run vertically to the vicinity of the open end (two axially symmetrical grooves are formed in the figure), and a plurality of double-ended needle engagement grooves 44 that are shorter than that (the vertical groove 41 in the figure).
And four are formed in axial symmetry). The longitudinal groove 41 is for engaging with the second engaging protrusion 62 of the vial guide 6 and lowering the vial guide 6 without rotating it. In this embodiment, the double-ended needle 3 has four engaging arms. The double-ended needle engaging groove 44 also serves as the double-headed needle engaging groove 44.
The double-ended needle engaging groove 44 may be provided with a step (not shown) for positioning the double-ended needle 3.
【００１３】隔壁４８には軸を中心とする透孔４６が形
成されており、隔壁４８の結合端側には透孔４６と同心
状に筒状のシール部材挿着部４７と結合部４３が突設さ
れている。透孔４６は後述の両頭針３の下部穿刺針３３
が挿通される孔であり、シール部材挿着部４７は、この
透孔４６に挿通され後述の溶解液容器２の連通口２１の
穿刺針ガイド２６に挿着された両頭針３の下部穿刺針３
３をシールするシール部材７を装着するためのものであ
る。このシール部材７は天面に下部穿刺針３３の直径よ
りも小さな透孔を有するキャップ状の部材であり、図１
に示すように、このシール部材挿着部４７と穿刺針ガイ
ド２６および隔壁４８で形成される空間に装着される。
また、結合部４３は溶解液容器２の連通口２１と結合す
る部分であり、図ではその内壁に雌ネジ４３１が形成さ
れており、連通口２１の外壁に形成された後述の雄ネジ
２１１と螺合されるようになっている。A through hole 46 is formed in the partition wall 48 about the axis, and a cylindrical seal member insertion portion 47 and a coupling portion 43 are concentric with the through hole 46 on the coupling end side of the partition wall 48. It is projected. The through hole 46 is the lower puncture needle 33 of the double-ended needle 3 described later.
The seal member insertion portion 47 is a lower puncture needle of the double-ended needle 3 that is inserted into the through hole 46 and is inserted into the puncture needle guide 26 of the communication port 21 of the dissolution liquid container 2 described later. Three
A seal member 7 for sealing 3 is attached. The sealing member 7 is a cap-shaped member having a through hole smaller than the diameter of the lower puncture needle 33 on the top surface.
As shown in FIG. 7, the seal member insertion portion 47, the puncture needle guide 26, and the partition wall 48 are mounted in the space formed therein.
Further, the coupling portion 43 is a portion that is coupled to the communication port 21 of the dissolution liquid container 2, and in the figure, a female screw 431 is formed on the inner wall thereof, and a male screw 211, which will be described later, formed on the outer wall of the communication port 21. It is designed to be screwed.
【００１４】ガイドカプセル４の結合端側は、隔壁４８
より下方に延長されてシール部材装着部４７および結合
部４３を内包するスカート部４２に形成されている。こ
のスカート部４２は、必ずしも必要なものではないが、
溶解液容器２の肩部２７と係合あるいは結合して（図１
では肩部２７に形成された環状段部２７１に係合してい
る）ガイドカプセル４と溶解液容器２の結合を強化して
いる。またスカート部４２の下端部にはガイドカプセル
４が外れないように好ましくは嵌合突起４５が形成され
ており、溶解液容器２の連通口２１に形成された後述の
嵌合溝２８と嵌合するようになっている。The connecting end side of the guide capsule 4 is a partition wall 48.
It is formed in a skirt portion 42 that extends downward and encloses the seal member mounting portion 47 and the coupling portion 43. The skirt portion 42 is not always necessary,
By engaging or coupling with the shoulder portion 27 of the dissolution liquid container 2 (see FIG.
Then, the coupling between the guide capsule 4 and the dissolving liquid container 2 which is engaged with the annular step portion 271 formed on the shoulder portion 27 is strengthened. A fitting protrusion 45 is preferably formed at the lower end of the skirt portion 42 so that the guide capsule 4 does not come off, and is fitted into a fitting groove 28, which will be described later, formed in the communication port 21 of the dissolution liquid container 2. It is supposed to do.
【００１５】尚、両頭針係合溝４４は縦走溝４１を兼ね
たものまたは別個に形成された２個だけであってもよ
い。また、連通口２１の穿刺針ガイド２６に両頭針３の
下部穿刺針３３が液密に挿着される場合には、シール部
材装着部４７は必ずしも必要なものではない。結合部４
３と溶解液容器２の連通口２１とは螺合あるいは溶着な
どにより気密に結合されるのが好ましいが、スカート部
４２と溶解液容器２の環状段部２７１とが溶着などによ
り気密に結合されている場合には、嵌合などにより結合
されてもよい。また、キャップ取外し手段８を設けない
場合には、環状突起４９は不要であり、この場合には、
ガイドカプセル４の開放端とキャップ５のスカート５５
の下端にそれぞれ相補的なアンダーカットを設け、キャ
ップ５が回動自在になるように嵌合すればよい。The double-ended needle engaging groove 44 may also serve as the vertical running groove 41 or may be only two separately formed. Further, when the lower puncture needle 33 of the double-ended needle 3 is liquid-tightly inserted into the puncture needle guide 26 of the communication port 21, the seal member mounting portion 47 is not always necessary. Connecting part 4
3 and the communication port 21 of the dissolution liquid container 2 are preferably airtightly coupled by screwing or welding, but the skirt portion 42 and the annular step portion 271 of the dissolution liquid container 2 are airtightly coupled by welding or the like. In this case, they may be joined by fitting or the like. Further, when the cap removing means 8 is not provided, the annular protrusion 49 is unnecessary, and in this case,
Open end of guide capsule 4 and skirt 55 of cap 5
Complementary undercuts may be provided at the lower ends of the respective caps, and the cap 5 may be fitted so as to be rotatable.
【００１６】連通手段として採用される両頭針３は、図
１に示すように薬剤容器１と溶解液容器２の間に配置さ
れており、通常、ステンレス鋼（ＳＵＳ３０４が好まし
い）または合成樹脂製のカヌラと合成樹脂製のハブから
構成されている。切れ味を重視する場合にはステンレス
鋼のカヌラが好ましいが、廃棄の問題および一体成型で
きるという点を考慮すれば合成樹脂製の両頭針が好まし
い。合成樹脂としては硬質の例えばＡＢＳ樹脂やポリカ
ーボネートなどが好適である。The double-ended needle 3 used as the communication means is disposed between the drug container 1 and the solution container 2 as shown in FIG. 1, and is usually made of stainless steel (SUS304 is preferable) or synthetic resin. It consists of a canula and a synthetic resin hub. When importance is attached to sharpness, stainless steel canula is preferable, but a double-ended needle made of synthetic resin is preferable in consideration of disposal problems and integral molding. A hard synthetic resin such as ABS resin or polycarbonate is suitable.
【００１７】両頭針３は下降してきた薬剤容器１の口部
１１のゴム栓１２を刺通し、さらには薬剤容器１ととも
に下降して溶解液容器２の連通口２１の閉鎖膜２２を刺
通することができるように、図５〜図７に示すように、
ハブ３１と薬剤容器１のゴム栓１２を刺通する上部穿刺
針３２および、溶解液容器２の連通口２１の閉鎖膜２２
を刺通する下部穿刺針３３からなり、好ましくはハブ３
１の先端にはガイドカプセル４の両頭針係合溝４４と係
合して両頭針３の下降移動を抑制する係合腕３４が設け
られている。係合腕３４はその先端の突出部分３４１で
両頭針係合溝４４と係合している。上部穿刺針３２は先
に薬剤容器１のゴム栓１２が刺通されるように下部穿刺
針３３より鋭利に形成してもよく、図では上部穿刺針３
２が中央部分の尖った刃先に形成され、下部穿刺針３３
がベベル状の刃先に形成されているが、刃先の形状は特
に限定されない。３６は薬液通路３５の上部穿刺針３２
側の出口であり、図では３個形成されているが、出口の
数は特に限定されない。尚、薬液通路３５は２個形成さ
れていてもよく、この場合、溶解液容器２を押圧しなく
ても薬液の移動が可能になる。The double-ended needle 3 pierces the rubber stopper 12 of the mouth 11 of the medicine container 1 that has descended, and further descends together with the medicine container 1 to pierce the closing membrane 22 of the communication port 21 of the solution container 2. 5 to 7, so that
An upper puncture needle 32 that pierces the hub 31 and the rubber stopper 12 of the drug container 1, and a closing film 22 of the communication port 21 of the dissolution liquid container 2.
A lower puncture needle 33 for piercing the
An engaging arm 34 that engages with the double-ended needle engaging groove 44 of the guide capsule 4 and suppresses the downward movement of the double-ended needle 3 is provided at the tip of 1. The engaging arm 34 is engaged with the double-ended needle engaging groove 44 at the protruding portion 341 at the tip thereof. The upper puncture needle 32 may be formed sharper than the lower puncture needle 33 so that the rubber stopper 12 of the drug container 1 can be pierced first.
2 is formed on the sharpened cutting edge of the central portion, and the lower puncture needle 33
Is formed on a beveled blade edge, but the shape of the blade edge is not particularly limited. 36 is the upper puncture needle 32 of the drug solution passage 35.
The number of outlets is not particularly limited, although three outlets are formed on the side. Two chemical liquid passages 35 may be formed, and in this case, the chemical liquid can be moved without pressing the dissolving liquid container 2.
【００１８】溶解液容器２は一般にポリエチレンやポリ
プロピレン、ポリエステルなどの比較的柔らかい合成樹
脂で形成された押圧変形自在な容器であり、その両端に
連通口２１と薬液取出口２３を有している。連通口２１
は両頭針３を介して薬剤容器１と連通するための口部で
あり、図３および図４に示すように、その先端は下部穿
刺針３３を挿着するためのパイプ状の穿刺針ガイド２６
に形成されており、この穿刺針ガイド２６の底に相当す
る部分には溶解液容器２を密封する閉鎖膜２２が形成さ
れている。そして連通口２１の外壁にはガイドカプセル
４の結合部４３と結合する手段として雄ネジ２１１が形
成されている。溶解液容器２の連通口２１側の肩部２７
にはガイドカプセル４のスカート部４２と係合するため
の環状段部２７１を形成してもよい。また、連通口２１
の外壁には、必要なら図４に示すようなガイドカプセル
４の嵌合突起４５を嵌入するための嵌合溝２８を形成し
てもよい。The solution container 2 is generally a container that can be pressed and deformed and is made of a relatively soft synthetic resin such as polyethylene, polypropylene or polyester, and has a communication port 21 and a chemical solution outlet 23 at both ends. Communication port 21
Is a mouth for communicating with the drug container 1 via the double-ended needle 3, and as shown in FIGS. 3 and 4, the tip thereof is a pipe-like puncture needle guide 26 for inserting the lower puncture needle 33.
The puncture needle guide 26 is provided with a closed film 22 for sealing the dissolution liquid container 2 at a portion corresponding to the bottom thereof. A male screw 211 is formed on the outer wall of the communication port 21 as a means for coupling with the coupling portion 43 of the guide capsule 4. Shoulder 27 on the side of the communication port 21 of the solution container 2
An annular step portion 271 for engaging with the skirt portion 42 of the guide capsule 4 may be formed therein. Also, the communication port 21
If necessary, a fitting groove 28 for fitting the fitting projection 45 of the guide capsule 4 may be formed on the outer wall of the above.
【００１９】尚、溶解液容器２内には生理食塩水、ぶど
う糖液、蒸留水、電解質液などの溶解液が収容されてい
るが、図面では省略している。また、溶解液容器２の連
通口２１は、図１や図３、図４に示すような閉鎖膜を底
とする穿刺針ガイド２６を設けた形状に限定するもので
はなく、薬液取出口２３と同様の閉鎖膜をゴム栓と押さ
え部材からなる密封部材で被った通常のボトルの場合と
同様の形状にしてもよい。但し、この場合には、ガイド
カプセル４のシール部材装着部４７は不要であり、透孔
４６が下部穿刺針３３のガイドとして機能する。The solution container 2 contains solutions such as physiological saline, glucose solution, distilled water and electrolyte solution, which are not shown in the drawing. Further, the communication port 21 of the dissolution liquid container 2 is not limited to the shape provided with the puncture needle guide 26 having a closed membrane as the bottom as shown in FIGS. The same closure membrane may be formed in the same shape as that of an ordinary bottle covered with a sealing member including a rubber stopper and a pressing member. However, in this case, the seal member mounting portion 47 of the guide capsule 4 is unnecessary, and the through hole 46 functions as a guide for the lower puncture needle 33.
【００２０】薬液取出口２３は通常のボトルの場合と同
様の構成をしており、例えば、図３に示すような、閉鎖
膜２３１の上に押さえ部材２５とこれに装着されたゴム
栓２４からなる密封部材を被せた構成が採用される。密
封部材の溶解液容器２への取り付けは、薬液取出口２３
の外壁に形成されたフランジ２３２と押さえ部材２５に
形成されたフランジ２５１の溶着により行われる。尚、
密封部材のゴム栓２４は、図示していないが、その表面
が汚染されないようにフィルムなどのカバー部材で保護
されていてもよい。The chemical solution outlet 23 has the same structure as that of a normal bottle. For example, as shown in FIG. 3, a pressing member 25 and a rubber stopper 24 attached to the pressing member 25 are provided on a closing membrane 231. A structure in which the following sealing member is covered is adopted. Attaching the sealing member to the dissolution liquid container 2 is performed with the chemical liquid outlet 23.
The welding is performed by welding the flange 232 formed on the outer wall of the and the flange 251 formed on the pressing member 25. still,
Although not shown, the rubber plug 24 of the sealing member may be protected by a cover member such as a film so that the surface thereof is not contaminated.
【００２１】本発明の輸液用容器は、溶解液容器２にガ
イドカプセル４を気密に取り付け、ガイドカプセル４の
中に両頭針３と薬剤容器１の口部１１側をセットし、ガ
イドカプセル４の開放端にキャップ５を気密に取り付け
れば完成する。この場合、ガイドカプセル４に両頭針３
の下部穿刺針３３をシールするシール部材７を装着して
もよく、また、ガイドカプセル４とキャップ５を結合す
るためにキャップ取外し手段８を利用してもよい。In the infusion solution container of the present invention, the guide capsule 4 is airtightly attached to the solution container 2, the double-ended needle 3 and the mouth 11 side of the drug container 1 are set in the guide capsule 4, and the guide capsule 4 It is completed when the cap 5 is airtightly attached to the open end. In this case, the guide capsule 4 and the double-ended needle 3
A seal member 7 for sealing the lower puncture needle 33 may be attached, and a cap removing means 8 may be used to connect the guide capsule 4 and the cap 5.
【００２２】キャップ５はガイドカプセル４の開放端を
密封するとともに、薬剤容器１を下方移動させる機能を
有しており、通常、図１２〜図１４に示すように、ガイ
ドカプセル４と同様の合成樹脂で筒状に形成される。そ
してキャップ５の天面５７には好ましくは吊り下げ手段
５２が設けられており、その側壁であるスカート５５の
下端には、キャップ５とガイドカプセル４の間を気密に
シールするシール部材５３を収容するためのシール部材
装着溝５４が形成され、スカート５５の内壁にはバイア
ルガイド６の第１の係合突起６１と係合する螺旋溝５１
が形成されている。吊り下げ手段５２には折り畳みが出
来るようにヒンジ部５９を設けてもよく、キャップ取外
し手段８を採用する場合には、スカート５５の下端部に
キャップ取外し手段８の溝と結合する突起５６を設けて
もよい。尚、５８は吊下孔である。The cap 5 has a function of sealing the open end of the guide capsule 4 and moving the drug container 1 downward. Usually, as shown in FIGS. 12 to 14, the same composition as the guide capsule 4 is used. It is made of resin and has a tubular shape. A suspending means 52 is preferably provided on the top surface 57 of the cap 5, and a lower end of a skirt 55 that is a side wall of the suspending means 52 accommodates a sealing member 53 that hermetically seals between the cap 5 and the guide capsule 4. Is formed with a seal member mounting groove 54, and a spiral groove 51 that engages with the first engaging protrusion 61 of the vial guide 6 is formed on the inner wall of the skirt 55.
Are formed. The hanging means 52 may be provided with a hinge part 59 so that it can be folded. When the cap removing means 8 is adopted, a projection 56 that is coupled to the groove of the cap removing means 8 is provided at the lower end of the skirt 55. May be. Reference numeral 58 is a hanging hole.
【００２３】螺旋溝５１はスカート５５の内壁を螺旋状
に縦走して設けられており、これとバイアルガイド６の
第１の係合突起６１と第２の係合突起６２、およびガイ
ドカプセル４の縦走溝４１とで薬剤容器押下手段を構成
している。図示していないが、螺旋溝５１の代わりに螺
旋状に斜走する突条を採用してもよく、この場合、バイ
アルガイド６の第１の係合突起６１は突条の下に接触す
るように配置される。また、薬剤容器押下手段として
は、図示していないが、キャップ５にバイアルガイド６
の第１の係合突起６１に相当する突起を形成し、バイア
ルガイド６にキャップ５の螺旋溝５１に相当する螺旋溝
と第２の係合突起６２を形成して、ガイドカプセル４の
縦走溝４１と組合せたものや、バイアルガイド６に第１
の係合突起６１とガイドカプセル４の縦走溝４１に相当
する縦走溝を形成し、ガイドカプセル４にバイアルガイ
ド６の第２の係合突起６２に相当する突起を形成して、
キャップ５の螺旋溝５１と組み合わせたものなども採用
可能である。The spiral groove 51 is provided longitudinally in a spiral shape on the inner wall of the skirt 55, and the first engaging projection 61 and the second engaging projection 62 of the vial guide 6 and the guide capsule 4 are provided. The vertically running groove 41 constitutes a medicine container pressing means. Although not shown, a spirally slanting protrusion may be used instead of the spiral groove 51, and in this case, the first engaging protrusion 61 of the vial guide 6 may contact under the protrusion. Is located in. Although not shown, the drug container pressing means is provided with a vial guide 6 on the cap 5.
Of the guide capsule 4 is formed by forming a protrusion corresponding to the first engaging protrusion 61 of the guide capsule 4, forming a spiral groove corresponding to the spiral groove 51 of the cap 5 on the vial guide 6, and a second engaging protrusion 62. 41 and the first vial guide 6
And a vertical groove corresponding to the vertical groove 41 of the guide capsule 4 is formed, and a protrusion corresponding to the second engaging projection 62 of the vial guide 6 is formed on the guide capsule 4.
A combination with the spiral groove 51 of the cap 5 can also be adopted.
【００２４】尚、螺旋溝５１や縦走溝４１でいう溝は、
図に示すような２つの突条で形成される樋状のものも含
んでおり、必ずしもキャップ５やガイドカプセル４の内
壁に穿設した溝に限定するものではない。また、キャッ
プ取外し手段８によるキャップ５とガイドカプセル４の
結合方法としては、結合する場合の反対方向に回した時
に結合解除される例えば螺合、ルアー結合その他適宜の
方法が採用可能である。The groove referred to as the spiral groove 51 or the longitudinal groove 41 is
It also includes a gutter-shaped one formed by two protrusions as shown in the drawing, and is not necessarily limited to the groove formed in the inner wall of the cap 5 or the guide capsule 4. Further, as a method of connecting the cap 5 and the guide capsule 4 by the cap removing means 8, for example, screwing, luer connection or other suitable method of releasing the connection when the cap 5 and the guide capsule 4 are rotated in the opposite direction to the connection can be adopted.
【００２５】図１５は本発明の他の実施例の要部断面を
示すものであり、薬液取出口２３に輸液用容器を自立さ
せるためのスタンド９を設けた構成になっている。スタ
ンド９は脚部９１と嵌合部９２からなり、嵌合部９２の
内壁で押さえ部材２５の外壁と嵌合している。スタンド
９の材質としては限定するものではないが一般に金属や
合成樹脂が使用される。FIG. 15 shows a cross section of the essential part of another embodiment of the present invention, in which a stand 9 is provided at the drug solution outlet 23 for making the infusion container self-supporting. The stand 9 includes a leg portion 91 and a fitting portion 92, and the inner wall of the fitting portion 92 is fitted to the outer wall of the pressing member 25. The material of the stand 9 is not limited, but generally metal or synthetic resin is used.
【００２６】次に、本発明の輸液用容器の使用について
詳しく説明する。キャップ５を時計方向に回すと、バイ
アルガイド６は、その第２の係合突起６２がガイドカプ
セル４の縦走溝４１に嵌入されているため回転が阻止さ
れる一方、その第１の係合突起６１がキャップ５の螺旋
溝５１に嵌入されているため、その内部に保持された薬
剤容器１とともに螺旋溝５１に沿って下方に移動する。
そして、薬剤容器１の口部１１のゴム栓１２が両頭針３
の上部穿刺針３２で穿刺され、バイアルガイド６は薬剤
容器１と両頭針３とともに更に下方に移動し、両頭針３
の上部穿刺針３２で薬剤容器１のゴム栓１２が刺通され
るとともに、下部穿刺針３３で溶解液容器２の連通口２
１の閉鎖膜２２が刺通される。こうして薬剤容器１と溶
解液容器２が両頭針３を介して連通されたら、次に、溶
解液容器２を上にしてこれを押圧すると、溶解液容器２
内の溶解液が薬剤容器１内に流入し、薬剤容器１内の乾
燥製剤と混合して薬液となる。次いで、キャップ５を上
にして、吊り下げ手段５２をハンガー（図示していな
い）などに架け、ポンピングにより溶解液容器２内に薬
剤容器１内の薬液を戻し、薬液取出口２３に輸液セット
などを結合すれば、輸液治療を行うことができる。尚、
使用後、輸液用容器を廃棄しようとする場合には、キャ
ップ取外し手段８を反時計方向に回せば、ガイドカプセ
ル４からキャップ５を容易に取り外すことができるの
で、薬剤容器１や両頭針３を取り出して、分別処分する
ことができる。ガイドカプセル４と溶解液容器２を取外
し可能にすることも可能である。Next, the use of the infusion container of the present invention will be described in detail. When the cap 5 is turned clockwise, the vial guide 6 is prevented from rotating because the second engagement protrusion 62 of the vial guide 6 is fitted into the longitudinal groove 41 of the guide capsule 4, while the first engagement protrusion thereof is blocked. Since 61 is fitted in the spiral groove 51 of the cap 5, it moves downward along the spiral groove 51 together with the drug container 1 held therein.
Then, the rubber stopper 12 of the mouth 11 of the medicine container 1 is replaced by the double-ended needle 3
Punctured by the upper puncture needle 32 of the vial guide 6, the vial guide 6 moves further downward together with the drug container 1 and the double-ended needle 3,
The rubber plug 12 of the drug container 1 is pierced by the upper puncture needle 32 of the above, and the communication port 2 of the solution container 2 is pierced by the lower puncture needle 33.
One closure membrane 22 is pierced. In this way, when the drug container 1 and the solution container 2 are communicated with each other via the double-ended needle 3, the solution container 2 is pressed upward with the solution container 2 facing up.
The dissolved solution inside flows into the drug container 1 and mixes with the dry preparation in the drug container 1 to become a drug solution. Next, with the cap 5 facing upward, the suspending means 52 is hung on a hanger (not shown) or the like, the drug solution in the drug container 1 is returned into the solution container 2 by pumping, and an infusion set or the like is put into the drug solution outlet 23. Infusion treatment can be performed by connecting still,
When the infusion container is to be discarded after use, the cap 5 can be easily removed from the guide capsule 4 by turning the cap removing means 8 counterclockwise. It can be taken out and sorted. It is also possible to make the guide capsule 4 and the solution container 2 removable.
【００２７】[0027]
【発明の効果】以上説明してきたことから明らかなよう
に、本発明の輸液用容器を採用することにより、操作が
容易で手間がかからず、混合された薬液が漏れる虞のな
い、無菌的に薬剤と溶解液を混合することのできる輸液
用容器を提供することができる。また、部品点数が少な
くて済むので、輸液用容器を安価に提供することができ
る。さらにまた、キャップ取外し手段８を設けることに
より、分別廃棄処分が可能になる、溶解液容器にスタン
ドを設けることにより輸液用容器を自立させることがで
きるので、場所をとらないで済む、などの利益を得るこ
とができる。As is apparent from the above description, by adopting the infusion container of the present invention, it is easy to operate, hassle-free, and there is no fear that the mixed drug solution leaks. It is possible to provide an infusion container capable of mixing a drug and a solution. Further, since the number of parts is small, it is possible to provide an infusion container at low cost. Further, by providing the cap removing means 8, it is possible to separate and dispose of the waste, and by providing a stand on the dissolution liquid container, the infusion container can be made to stand on its own, so that it does not occupy a lot of space. Can be obtained.
【図１】本発明の輸液用容器の一実施例の断面図であ
る。FIG. 1 is a cross-sectional view of one embodiment of the infusion container of the present invention.
【図２】図１の薬剤容器の断面図である。2 is a cross-sectional view of the drug container of FIG.
【図３】図１の溶解液容器の断面図である。FIG. 3 is a cross-sectional view of the solution container of FIG.
【図４】図３の平面図である。FIG. 4 is a plan view of FIG. 3;
【図５】図１の両頭針の断面図である。5 is a cross-sectional view of the double-ended needle of FIG.
【図６】図５の底面図である。FIG. 6 is a bottom view of FIG.
【図７】図５の平面図である。FIG. 7 is a plan view of FIG.
【図８】図１のバイアルガイドに把手を設けたものの断
面図である。8 is a cross-sectional view of the vial guide of FIG. 1 provided with a handle.
【図９】図８の底面図である。FIG. 9 is a bottom view of FIG.
【図10】図１のガイドカプセルの断面図である。10 is a cross-sectional view of the guide capsule of FIG. 1.
【図11】図１０の平面図である。11 is a plan view of FIG. 10.
【図12】図１のキャップの側面図である。FIG. 12 is a side view of the cap of FIG. 1.
【図13】図１２のＸ−Ｘ線断面図である。13 is a cross-sectional view taken along line XX of FIG.
【図14】図１２の平面図である。14 is a plan view of FIG. 12.
【図15】他の実施例の要部断面図である。FIG. 15 is a cross-sectional view of main parts of another embodiment.
【図16】図１５のスタンドの断面図である。16 is a cross-sectional view of the stand of FIG.
【図17】図１６の底面図である。FIG. 17 is a bottom view of FIG. 16.
１ 薬剤容器 ２ 溶解液容器 ３ 両頭針 ４ ガイドカプセル ５ キャップ ６ バイアルガイド ８ キャップ取外し手段 ９ スタンド ２１ 連通口 ２２ 閉鎖膜 ２３ 薬液取出口 ２６ 穿刺針ガイド ３１ ハブ ３２ 上部穿刺針 ３３ 下部穿刺針 ４１ 縦走溝 ５１ 螺旋溝 ６１ 第１の係合突起 ６２ 第２の係合突起 ６９ 把手 1 drug container 2 dissolution liquid container 3 double-headed needle 4 guide capsule 5 cap 6 vial guide 8 cap removing means 9 stand 21 communication port 22 occluding membrane 23 drug solution outlet 26 puncture needle guide 31 hub 32 upper puncture needle 33 lower puncture needle 41 longitudinal running Groove 51 Spiral groove 61 First engagement protrusion 62 Second engagement protrusion 69 Handle
Claims (7)
該薬剤容器との連通口と薬液取出口とをその両端に有す
る押圧変形自在な合成樹脂製の溶解液容器と、該薬剤容
器の口部と溶解液容器の連通口の間に介在された上下両
端に穿刺針を有する両頭針と、開放端と前記溶解液容器
の連通口外壁との結合端を有し、前記薬剤容器の一部お
よび両頭針を下方向スライド可能に収容するガイドカプ
セル、および該ガイドカプセルの開放端を密封するキャ
ップから構成されてなり、キャップの内壁とガイドカプ
セルの内壁および薬剤容器の外壁に協働して薬剤容器を
下方移動させる薬剤容器押下手段を設け、キャップを回
転させた時に薬剤容器が回転することなく下方移動して
両頭針に達し、さらに該両頭針とともに下方移動するこ
とにより、薬剤容器の口部のゴム栓と溶解液容器の連通
口の密閉部材が両頭針によって刺通され、薬剤容器と溶
解液容器が連通されるようにしてなる輸液用容器。1. A drug container having a mouth sealed with a rubber stopper,
A solution container made of a synthetic resin that is press-deformable and has a communication port with the drug container and a drug solution outlet at its both ends, and an upper and lower part interposed between the mouth part of the drug container and the communication port of the solution container. A double-ended needle having puncture needles at both ends, a guide capsule having a connecting end of the open end and the outer wall of the communication port of the dissolution liquid container, and a part of the drug container and the double-ended needle to be slidable downward, and The cap comprises a cap that seals the open end of the guide capsule. The cap is rotated by cooperating with the inner wall of the cap, the inner wall of the guide capsule and the outer wall of the drug container to move the drug container downward. When the drug container moves downward without rotating and reaches the double-ended needle, and further moves downward together with the double-headed needle, the rubber stopper at the mouth of the drug container and the sealing member at the communication port of the solution container become both. Pierced by the needle, infusion container drug container and solvent container is so as to be communicated.
方に向かって斜走する平行な複数の螺旋溝と、ガイドカ
プセル内壁の縦走する複数の縦走溝と、薬剤容器外壁の
底部に設けられた前記斜走溝に嵌入される複数の第１の
係合突起、および薬剤容器の肩部に設けられた前記縦走
溝に嵌入される複数の第２の係合突起から構成されてな
る請求項１に記載の輸液用容器。2. The medicine container pressing means is provided in a plurality of parallel spiral grooves obliquely running downward to the inner wall of the cap, a plurality of vertically running grooves of the inner wall of the guide capsule, and a bottom portion of the outer wall of the medicine container. 2. A plurality of first engaging projections fitted into the oblique running grooves and a plurality of second engaging projections fitted into the vertical running grooves provided on the shoulder portion of the medicine container. The infusion container described in.
りに、通常の薬剤容器をバイアルガイドに挿着し、該バ
イアルガイドの外壁に前記第１の係合突起および第２の
係合突起に相当する突起を設けてなる請求項２に記載の
輸液用容器。3. Instead of providing an engaging projection on the outer wall of the drug container, a usual drug container is inserted into a vial guide, and the first engaging projection and the second engaging projection are provided on the outer wall of the vial guide. The infusion container according to claim 2, which is provided with a protrusion corresponding to.
求項１〜３のいずれかに記載の輸液用容器4. The infusion container according to claim 1, wherein the cap is provided with suspending means.
自立させるためのスタンドを設けてなる請求項１〜４の
いずれかに記載の輸液用容器。5. The infusion container according to claim 1, wherein a stand for making the infusion container self-support is provided at the drug solution outlet of the dissolution liquid container.
設けてなる請求項１に記載の輸液用容器。6. The infusion container according to claim 1, wherein the guide capsule is provided with a cap removing means.
ャップ取り外し後にバイアルを取り出せるようにしてな
る請求項６に記載の輸液用容器。7. The infusion container according to claim 6, wherein a handle is provided on the top surface of the vial guide so that the vial can be taken out after removing the cap.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5100205A JP2551318B2 (en) | 1992-04-10 | 1993-04-02 | Infusion container |
| TW82106141A TW259704B (en) | 1992-04-10 | 1993-07-31 | Fluid container |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11803692 | 1992-04-10 | ||
| JP4-118036 | 1992-04-10 | ||
| JP5100205A JP2551318B2 (en) | 1992-04-10 | 1993-04-02 | Infusion container |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0614976A JPH0614976A (en) | 1994-01-25 |
| JP2551318B2 true JP2551318B2 (en) | 1996-11-06 |
Family
ID=26441270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5100205A Expired - Fee Related JP2551318B2 (en) | 1992-04-10 | 1993-04-02 | Infusion container |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2551318B2 (en) |
| TW (1) | TW259704B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4725439A (en) * | 1984-06-29 | 1988-02-16 | Alza Corporation | Transdermal drug delivery device |
| WO1995000101A1 (en) * | 1993-06-28 | 1995-01-05 | Roussel Morishita Co., Ltd. | Medical container |
| JPH08126683A (en) * | 1994-10-31 | 1996-05-21 | Fujisawa Pharmaceut Co Ltd | Container for transfusion |
| DE69628284D1 (en) * | 1995-02-13 | 2003-06-26 | Fujisawa Pharmaceutical Co | TRANSFUSION CONTAINER |
| EP2765972B1 (en) * | 2011-10-14 | 2016-01-13 | Novo Nordisk Health Care AG | Pre-assembled fluid transfer arrangement |
| KR101927194B1 (en) * | 2016-12-01 | 2018-12-11 | 제이씨텍(주) | Sap container with injection medicine bottle |
| KR101855883B1 (en) * | 2016-12-01 | 2018-06-20 | 제이씨텍(주) | Sap container set with injection medicine bottle |
-
1993
- 1993-04-02 JP JP5100205A patent/JP2551318B2/en not_active Expired - Fee Related
- 1993-07-31 TW TW82106141A patent/TW259704B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0614976A (en) | 1994-01-25 |
| TW259704B (en) | 1995-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08126683A (en) | Container for transfusion | |
| JP3456019B2 (en) | Liquid introduction needle and aid for dissolving dry preparation using the same | |
| JP3146465B2 (en) | Chemical injection device | |
| JPH05317383A (en) | Solution container equipped with means for communicating with chemical container | |
| JPH06239352A (en) | Solution injection set | |
| EP0598918A1 (en) | Medical container | |
| JP2000185085A (en) | Lid of medical container with integral spike insertion means provided with recess | |
| US5348550A (en) | Drug vessel | |
| JP2551318B2 (en) | Infusion container | |
| JP3514505B2 (en) | Manufacturing method of solution container | |
| JP3565609B2 (en) | Lysis solution injection set | |
| JP3345860B2 (en) | Infusion container | |
| JPH08238300A (en) | Infusion container | |
| JPH0642676Y2 (en) | Infusion bag | |
| JP3070044B2 (en) | Infusion container with communication means | |
| JP2550858B2 (en) | Infusion container | |
| JP3415714B2 (en) | Chemical transfer device and chemical transfer system | |
| JP3175127B2 (en) | Infusion container | |
| JP3213928B2 (en) | Dissolution liquid container provided with means for communicating with the drug container | |
| JPH04132554A (en) | Parenteral fluid container | |
| JPH05329192A (en) | Liquid transfusion container | |
| JP2000070341A (en) | Transfusion container having double-headed needle | |
| JP2607232Y2 (en) | Infusion container | |
| JP3047388B2 (en) | Infusion container having communication means with the drug container | |
| JPH04253863A (en) | Transfusion container |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090822 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090822 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100822 Year of fee payment: 14 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110822 Year of fee payment: 15 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110822 Year of fee payment: 15 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120822 Year of fee payment: 16 |
|
| LAPS | Cancellation because of no payment of annual fees |